Fetal Exposure to Antiseizure Medications Shows No Cognitive Adverse Effects
Researchers compared neurodevelopmental outcomes in children with and without fetal exposure to antiseizure medications.
Diagnosis & Disease Information
Immunization Update: 2024 Vaccine Schedules for Infants, Children, and Adolescents
After sharp declines during the COVID-19 pandemic, vaccination rates among children are rising but vaccine hesitancy continues among many parents.
FDA Approves RSV Vaccine Abrysvo for Use During Pregnancy to Protect Infants
Abyrsvo is the first vaccine approved for pregnant individuals to prevent RSV disease in infants.
As Vaping Among Teens, Young Adults Rapidly Increases, So Do Health Concerns
Vaping, which delivers more nicotine than smoking, has exponentially increased in teens and adults. Harmful effects are evident, but long-term research is lacking.
CDC Recommends Routine Use of Beyfortus for RSV Disease Prevention in Infants
Beyfortus is a long-acting anti-RSV monoclonal antibody.
Unexplained Increase in Pediatric Intracranial Infections in Nevada
Authors highlighted the increase in rare pediatric intracranial infections in the Southern Nevada Health District over the past 3 years.
Family History, Psychiatric Comorbidities Predict Tic Disorder Persistence Into Adulthood
Researchers sought to estimate the percentage of tic disorders in childhood that continued into adulthood, as well as the risk factors associated with tic disorder persistence.
Food Allergy Rates Highest in Asian, Black, and Hispanic Individuals
Investigators sought to determine the distribution of food allergies among US individuals by race/ethnicity and socioeconomic level.
Adult Childhood Cancer Survivors at Risk for Cognitive Impairment With Age
Researchers sought to determine whether long-term survivors of childhood cancer may be at a higher risk for new neurocognitive impairment and decline in adulthood.
Empagliflozin Approved for Pediatric Patients With Type 2 Diabetes
The approval of empagliflozin for pediatric T2DM was based on data from the phase 3 DINAMO trial.
- Loading...
Loading...
Loading... 
Loading...